Jason Williams, MD, discusses the development of intratumoral immunotherapy, as well as trial results from his poster presentation at the 34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019).
Jason Williams, MD
Advertisement
Articles by Jason Williams, MD
Advertisement
Latest Updated Articles
Jason Williams, MD, on Intratumoral Immunotherapy Advances at SITC 2019Published: November 12th 2019 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Cancer Vaccine/Pembrolizumab Improves PFS in Treatment-Naive Melanoma
2
Relacorilant Regimen Improves PFS in Platinum-Resistant Ovarian Cancer
3
Sacituzumab Tirumotecan Improves Survival in Second-Line EGFR+ NSCLC
4
FDA Issues CRL for Dasatinib in CML/ALL
5
